ClinicalTrials.Veeva

Menu

Coronary CT Angio Evaluating Graft Patency in ACS Patients Treated With DAPT or Single ASA After CABG (CoCAP)

U

University Hospital, Linkoeping

Status

Enrolling

Conditions

Acute Coronary Syndrome
Coronary Bypass Stenosis

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to compare the presence of graft patency in single aspirin vs dual anti platelet therapy (DAPT) treatment including ticagrelor in patients with acute coronary syndrome (ACS) treated with coronary artery bypass surgery (CABG). Follow up time is 12-36 months postoperatively and the patency will be evaluated with coronary computed tomography angiography (CCTA)

Enrollment

360 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Previously included in TACSI-trial

Exclusion criteria

  • Highly irregular heart rhythm (i.e. atrial fibrillation)
  • Chronic kidney disease with estimated glomerular filtration rate (eGFR) <45ml/min/1,73m2
  • Body weight >120 kg
  • Previous severe allergic reaction (i.e. anaphylactic reaction) to iodine-based contrast agents
  • Not able to communicate
  • Not willing to participate

Trial contacts and locations

6

Loading...

Central trial contact

Sofia Sederholm Lawesson, MD, PhD; Jonas Holm, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems